ILK and myocardial infarction: In addition, bone marrow mesenchymal stem cells (BMSCs) with ILK transfection via intracoronary-administered can inhibit myocardial collagen synthesis and proliferation of fibroblast after myocardial infarction in pigs37, at the same time increasing the survival rate, proliferation, differentiation and angiogenesis of MSCs transplantation, significantly improving the myocardial function38.